A reform of medical device establishment licensing has been on the books since it appeared in the Canada Gazette on June 17, 2026. Health Canada sets its effective date at December 14, 2026. For an importer or a distributor of medical devices, three things change in practice: a supplier list to declare, written procedures to formalize, and a new Health Canada power to attach terms and conditions to your licence. Here is what to check before mid December.

The establishment licence, what it is and who holds one

A medical device establishment licence (MDEL in English, LEIM in French) is issued to a business and authorizes it to carry out an activity: importing or distributing medical devices intended for the Canadian market. According to Health Canada, only importation and distribution are activities licensable under an MDEL. Manufacturing as such is not licensable under an MDEL, but a Class I manufacturer that imports or distributes its own devices must hold one.

The regime therefore applies to every importer of medical devices, every distributor, and Class I manufacturers who sell directly to retailers or health care facilities. Foreign companies looking to enter Canada are concerned as soon as a Canadian link imports or distributes their products.

Change 1: the supplier list becomes mandatory

The most concrete change for most businesses is the declaration of suppliers. The holder or applicant of an MDEL must now provide the name and address of the manufacturers of each device it imports or distributes, along with the name and address of each supplier who sells it those devices. It must also indicate the class (I, II, III or IV) of each device.

This information is not static: it is updated at the annual licence review, which is filed before April 1 of each year. Health Canada’s goal is to gain better visibility over the supply chain and to identify a non compliant supplier more quickly. In plain terms, the traceability of your suppliers becomes a condition of your licence.

Change 2: foreign distributors leave the MDEL loop

Until now, the licensing requirement could reach both the Canadian importer and the foreign distributor, which created a duplication. The reform removes it: a foreign distributor that sells to a Canadian importer holding an MDEL no longer needs to hold its own licence, and the Canadian importer no longer has to verify that it holds one. This is a real reduction in burden for chains that run through a licensed Canadian importer.

The relief is targeted, not general. Retailers and health care facilities that do not hold an MDEL must still make sure their foreign suppliers are licensed. Before reorganizing a supply chain on the strength of this simplification, you therefore need to verify who, in the chain, actually holds a licence.

Change 3: written procedures, in black and white

The reform makes explicit the documented procedures that manufacturers, importers and distributors must establish and maintain. For all classes: keeping distribution records, and handling complaints and recalls. Incident reporting is added to this.

For Class II, III and IV devices, the written procedures must also cover handling, storage, delivery, installation, servicing and corrective action. Importers of those same classes must in addition have a procedure to relay safety risk information received from abroad. These expectations already came up during inspections: they now become a clear written requirement, verifiable with the document in hand.

Change 4: Health Canada can attach terms and conditions to your licence

The new section 48.1 of the Regulations lets Health Canada add terms and conditions to an MDEL when it becomes aware of a risk associated with a licensable activity. The authority can thus frame a specific point of non compliance without suspending the entire licence. This mechanism aligns medical devices with what already exists for drug and blood establishment licences.

For a holder, this means a condition can be set in a targeted and documented way. It is better to keep a compliance file up to date, able to respond quickly to a Health Canada request.

Foreign companies: the licence on one side, the device licence on the other

For a foreign company that wants to sell a medical device in Canada, two distinct authorizations come together. The medical device licence covers the product: a Class II, III or IV device must hold a device licence before it can be sold. The establishment licence covers the activity: it is the Canadian link that imports or distributes, the importer or the distributor, that must hold an MDEL. The December 14, 2026 reform does not touch the product’s device licence; it changes the obligations of the business that carries out the activity.

In practice, a foreign company relies on a Canadian importer holding an MDEL, and it is that importer who will have to declare its suppliers, including the foreign manufacturer, and maintain the required written procedures. The simplification granted to foreign distributors therefore does not remove the need to verify, case by case, who holds which authorization in the chain. That is the first reflex to have before building or reorganizing an entry into the Canadian market.

What to do before December 14, 2026

What this changes for your business

The reform eases one licensing duplication, but it raises the bar on two fronts: the traceability of your suppliers and the formalization of your procedures. It also gives Health Canada a finer tool to intervene. Businesses that treat this shift as a documentation project starting now will reach mid December without a scramble and without regulatory risk. Those who wait until the last week will find that a complete supplier list and written procedures cannot be improvised.